PhronesisThe setup
Let S⁰ be health — the biological ground state. Not perfect function. The minimum-cost configuration the body can sustain without external forcing.
Let ξ(t) be deviation from health at time t. This is disease. The body is displaced from S⁰.
Let D(ξ) be the biological cost of that displacement — metabolic expenditure, immune load, structural stress. The body pays this continuously while displaced.
Let Φ_disease = ∫ D(ξ) dt be the total cost the body paid over the course of illness. This is what disease actually costs, paid in energy, tissue, time.
Treatment
A treatment T defines a path back toward S⁰. It intervenes in the trajectory of ξ, redirecting it toward ground.
The displacement cost of treatment:
This is what the treatment actually does — the physical work performed on the body. Some treatments are cheap: a cheap molecule, three days, restored. Some are expensive: surgery, months of rehab, genuine displacement of tissue and time.
Optimal treatment minimizes Φ_T — the least total displacement, the least cost to the body. Not the cheapest drug. The path that disturbs least.
The glitch
In a fair system:
In the current system:
The patient arrives displaced. Their willingness to pay is proportional to ξ — to the severity of their disease, their desperation, the distance they are from ground. The market reads that distance and charges accordingly.
But Φ_T — the actual work performed by the treatment — may be small. A molecule synthesized for a few cents that restores S⁰ in three days. The displacement cost of that intervention is near zero, while the ledger charges hundreds of dollars.
G is extracted from ξ — from the patient's displacement. It corresponds to no physical work performed. It is surplus taken from the state of being sick, not from any treatment given.
Illustrative, not a quoted price for any real drug — a molecule synthesized for pennies, charged at hundreds, to show the shape of the gap.
The fairness theorem
In any system where cost is set by displacement ξ rather than displacement cost Φ_T, accumulated surplus G grows without bound as long as disease exists.
The argument:
- Disease is always present in any population — ξ > 0 for some at all t.
- If C(T) ∝ ξ and Φ_T is bounded, then G > 0 whenever ξ is large.
- G accumulates continuously into the extracting party's balance.
- No physical work corresponds to G.
The ledger shows a profitable industry. The model reads it as a system extracting from ξ rather than doing Φ_T — pricing on displacement, not on the work of undoing it.
Corollary: under this model, the pharmaceutical and insurance markets, as currently structured, are glitch economies — pricing on ξ, not Φ. Their profits are not, in this account, returns on work done. They are G extracted from displaced people.
What fair medicine looks like
If C(T) ∝ Φ_T:
| Condition | Fair system | Current system |
|---|---|---|
| Cheap synthesis | Low C, regardless of disease severity | High C because patient is desperate |
| Complex surgery | High C — Φ_T is genuinely high | High C — but partly because of ξ |
| Generic drug | Cost = synthesis + distribution | Cost = what the market will bear |
| Urgency | Increases obligation to treat, not price | Increases price directly |
| Insurance | Pools Φ across population | Extracts G from the displaced |
Fair medicine requires a ledger that tracks Φ, not ξ. That ledger does not currently exist. Building it — measuring the actual displacement cost of treatments, divorcing price from desperation — is the work.
DC8 applied
The fair business model for medicine:
Small margin on actual treatment cost. Large volume — many patients, many treatments. Real displacement as the unit of exchange.
This is generic drugs done right. Vaccines. A public-insurance model at its best. Profit from volume of actual healing, not from the depth of individual suffering.
It is stable because it corresponds to real work. G does not accumulate. The loop does not close on extraction.
This is thermodynamics
D(ξ) is entropy production. Φ is cumulative entropy. DC5 is the second law, in this framework's own numbering. The medical system is not exempt from that structure — it just hasn't been priced as if it isn't.
The body accumulates displacement. Treatment performs work. A fair market charges for the work. This one charges for the displacement instead.
The gap is G — unpriced work owed back: to the patient, to the system, to the body that paid Φ_disease alone, without compensation.
This applies the site's displacement framework (S⁰, ξ, Φ, DC1–DC8) as a model to drug pricing — not peer-reviewed clinical or health-economics research.